D. E. Shaw & Co., Inc. Rx Sight, Inc. Transaction History

D. E. Shaw & Co., Inc.

$125 Billion
Q2 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Rx Sight, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,321,330 shares of RXST stock, worth $9.71 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,321,330

Previous 22,000 5906.05%

Holding current value

$9.71 Million

Previous $555,000 2994.95%

% of portfolio

0.01%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$13.0 - $26.12 $16.9 Million - $33.9 Million	1,299,330 Added 5906.05%	1,321,330 $17.2 Million
Q1 2025 May 15, 2025	BUY	$24.37 - $35.84 $302,919 - $445,491	12,430 Added 129.89%	22,000 $555,000
Q4 2024 Feb 14, 2025	SELL	$33.66 - $54.73 $3.12 Million - $5.08 Million	-92,821 Reduced 90.65%	9,570 $329,000
Q3 2024 Nov 14, 2024	SELL	$40.78 - $57.04 $7.03 Million - $9.84 Million	-172,447 Reduced 62.74%	102,391 $5.06 Million
Q2 2024 Aug 14, 2024	SELL	$50.42 - $64.29 $3.44 Million - $4.38 Million	-68,142 Reduced 19.87%	274,838 $16.5 Million
Q1 2024 May 15, 2024	BUY	$35.51 - $57.92 $5.13 Million - $8.36 Million	144,410 Added 72.72%	342,980 $17.7 Million
Q4 2023 Feb 14, 2024	BUY	$20.91 - $40.9 $2.31 Million - $4.51 Million	110,283 Added 124.91%	198,570 $8.01 Million
Q3 2023 Nov 14, 2023	SELL	$27.05 - $33.37 $1.28 Million - $1.58 Million	-47,209 Reduced 34.84%	88,287 $2.46 Million
Q2 2023 Aug 14, 2023	BUY	$16.37 - $28.9 $2.22 Million - $3.92 Million	135,496 New	135,496 $3.9 Million

Others Institutions Holding RXST

# of Institutions

189

Shares Held

36.2M

Call Options Held

42.2K

Put Options Held

103K

View Full List

About RxSight, Inc.

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $203M
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

More about RXST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account